Crossmark

NeuroAid™-II (MLC901) provides neuroprotection and enhances neuronal cell survival against kainic acid-induced excitotoxicity in vitro by activating the PI3K/AKT pathway

Crossref DOI link: https://doi.org/10.1186/s43094-025-00782-x

Published Online: 2025-03-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anjum, Anam

Yazid, Muhammad Dain

Daud, Muhammad Fauzi

Idris, Jalilah

Ng, Angela Min Hwei

Naicker, Amaramalar Selvi

Ismail, Ohnmar Htwe

Athi Kumar, Ramesh Kumar

Lokanathan, Yogeswaran https://orcid.org/0000-0002-9548-6490
Funding

Funding for this research was provided by:

Faculti Perbutan, Universiti Kebangsaan Malaysia (FF-2019-542/1)

Moleac pte ltd (FF-2019-542)
License Information

Text and Data Mining valid from 2025-03-07

Version of Record valid from 2025-03-07
More Information

Article History

Received: 27 August 2024

Accepted: 20 February 2025

First Online: 7 March 2025

Declarations

:

: This research was conducted after getting ethical approval from the Universiti Kebangsaan Malaysia Research Ethical Committee (UKMREC), with approval number UKM.FPR.SPI 800–2/29/12.

: All authors give consent for the publication of this work to be published in the Future Journal of Pharmaceutical Sciences.

: The authors confirm that they have no competing interests to disclose while preparing this article.

Document is current

Any future updates will be listed below